Introduction
The Mukka Proteins Limited initial public offering (IPO) has garnered significant attention from investors. As the subscription period concludes, let’s delve into the subscription status, market size, and growth prospects of this Karnataka-based company.
Mukka Proteins IPO Subscription status
The table displays the subscription status of the Mukka Proteins IPO, indicating the level of interest from different categories of investors:
Qualified Institutional Buyers: This category, which typically includes large financial institutions and banks, has shown a subscription ratio of 189.28 times, indicating a high level of interest from this group.
Non-Institutional Investors: These are individual investors who are not classified as institutions. They have subscribed to the IPO at a ratio of 242.86 times, demonstrating significant interest from this segment of investors.
Retail Individual Investors: These are individual investors who typically invest smaller amounts compared to institutional investors. They have subscribed to the IPO at a ratio of 58.52 times, indicating a moderate level of interest from this group.
Subscription Status | Subscription Ratio |
---|---|
Qualified Institutional Buyers | 189.28x |
Non-Institutional Investors | 242.86x |
Retail Individual Investors | 58.52x |
Total | 136.99x |
Mukka Protins IPO Details
- Issue Size: The IPO was for Rs 224.00 crores, with a fresh offering of 8 crore shares.
- Price Range: The IPO price band was ₹26 to ₹28 per share.
- Minimum Application Lot Size:
- Retail investors: A minimum of 535 shares (investment of at least ₹14,980).
- NII and business NII: ₹209,720 for 14 lots (7,490 shares) and ₹1,003,660 for 67 lots (35,845 shares), respectively.
- Listing Date: Mukka Proteins IPO is scheduled to list on the BSE and NSE on Thursday, March 7, 2024.